Edmond de Rothschild Investment Partners (EdRip) has led a €34m series-B round for French biotech MedDay Pharmaceuticals, alongside existing backers Sofinnova Partners and BPI France.
Gyrus is fundraising for both its open-ended Cortex Fund and closed-ended Principal Fund
Fund targets companies operating in a wide range of sectors and deploys tickets in the $50-500m range
Predecessor vehicle PEC III closed on $389m in October 2017 and is now fully deployed
Arlington expects to put fresh capital into the business and grow it through acquisitions